265 results on '"Hersh, AL"'
Search Results
2. Appropriateness of Antibiotic Prescribing in United States Children’s Hospitals: A National Point Prevalence Survey
- Author
-
Tribble, AC, Lee, BR, Flett, KB, Handy, LK, Gerber, JS, Hersh, AL, Kronman, MP, Terrill, CM, Sharland, M, and Newland, JG
- Abstract
BACKGROUND: Studies estimate that 30-50% of antibiotics prescribed for hospitalized patients are inappropriate, but pediatric data are limited. Characterization of inappropriate prescribing practices for children are needed to guide pediatric antimicrobial stewardship. METHODS: Cross-sectional analysis of antibiotic prescribing at 32 US children's hospitals. Subjects included hospitalized children with ≥1 antibiotic order at 0800 on one day per calendar quarter, over six quarters (Quarter 3 2016 - Quarter 4 2017). Antimicrobial stewardship program (ASP) physicians and/or pharmacists used a standardized survey to collect data on antibiotic orders and evaluate appropriateness. The primary outcome was the percentage of antibiotics prescribed for infectious use that were classified as suboptimal, defined as inappropriate or needing modification. RESULTS: Of 34 927 children hospitalized on survey days, 12 213 (35.0%) had ≥1 active antibiotic order. Among 11 784 patients receiving antibiotics for infectious use, 25.9% were prescribed ≥1 suboptimal antibiotic. Of the 17 110 antibiotic orders prescribed for infectious use, 21.0% were considered suboptimal. Most common reasons for inappropriate use were bug-drug mismatch (27.7%), surgical prophylaxis >24 hours (17.7%), overly broad empiric therapy (11.2%), and unnecessary treatment (11.0%). The majority of recommended modifications were to stop (44.7%) or narrow (19.7%) the drug. ASPs would not have routinely reviewed 46.1% of suboptimal orders. CONCLUSIONS: Across 32 children's hospitals, approximately 1 in 3 hospitalized children are receiving one or more antibiotics at any given time. One quarter of these children are receiving suboptimal therapy, and nearly half of suboptimal use is not captured by current ASP practices.
- Published
- 2020
3. Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
- Author
-
Chiotos, K, Hayes, M, Kimberlin, DW, Jones, SB, James, SH, Pinninti, SG, Yarbrough, A, Abzug, MJ, MacBrayne, CE, Soma, VL, Dulek, DE, Vora, SB, Waghmare, A, Wolf, J, Olivero, R, Grapentine, S, Wattier, RL, Bio, L, Cross, SJ, Dillman, NO, Downes, KJ, Timberlake, K, Young, J, Orscheln, RC, Tamma, PD, Schwenk, HT, Zachariah, P, Aldrich, M, Goldman, DL, Groves, HE, Lamb, GS, Tribble, AC, Hersh, AL, Thorell, EA, Denison, MR, Ratner, AJ, Newland, JG, Nakamura, MM, Chiotos, K, Hayes, M, Kimberlin, DW, Jones, SB, James, SH, Pinninti, SG, Yarbrough, A, Abzug, MJ, MacBrayne, CE, Soma, VL, Dulek, DE, Vora, SB, Waghmare, A, Wolf, J, Olivero, R, Grapentine, S, Wattier, RL, Bio, L, Cross, SJ, Dillman, NO, Downes, KJ, Timberlake, K, Young, J, Orscheln, RC, Tamma, PD, Schwenk, HT, Zachariah, P, Aldrich, M, Goldman, DL, Groves, HE, Lamb, GS, Tribble, AC, Hersh, AL, Thorell, EA, Denison, MR, Ratner, AJ, Newland, JG, and Nakamura, MM
- Abstract
BACKGROUND: Although coronavirus disease 2019 (COVID-19) is mild in nearly all children, a small proportion of pediatric patients develop severe or critical illness. Guidance is therefore needed regarding use of agents with potential activity against severe acute respiratory syndrome coronavirus 2 in pediatrics. METHODS: A panel of pediatric infectious diseases physicians and pharmacists from 18 geographically diverse North American institutions was convened. Through a series of teleconferences and web-based surveys, a set of guidance statements was developed and refined based on review of best available evidence and expert opinion. RESULTS: Given the typically mild course of pediatric COVID-19, supportive care alone is suggested for the overwhelming majority of cases. The panel suggests a decision-making framework for antiviral therapy that weighs risks and benefits based on disease severity as indicated by respiratory support needs, with consideration on a case-by-case basis of potential pediatric risk factors for disease progression. If an antiviral is used, the panel suggests remdesivir as the preferred agent. Hydroxychloroquine could be considered for patients who are not candidates for remdesivir or when remdesivir is not available. Antivirals should preferably be used as part of a clinical trial if available. CONCLUSIONS: Antiviral therapy for COVID-19 is not necessary for the great majority of pediatric patients. For those rare cases of severe or critical disease, this guidance offers an approach for decision-making regarding antivirals, informed by available data. As evidence continues to evolve rapidly, the need for updates to the guidance is anticipated.
- Published
- 2020
4. Factors associated with prolonged emergency department length of stay for admitted children
- Author
-
Bekmezian, A, Chung, PJ, Cabana, MD, Maselli, JH, Hilton, JF, and Hersh, AL
- Subjects
Male ,Time Factors ,overcrowding ,Emergency Care ,Paediatrics and Reproductive Medicine ,Databases ,Hospital ,Patient Admission ,Clinical Research ,Risk Factors ,Confidence Intervals ,Odds Ratio ,Humans ,NHAMCS ,Child ,Preschool ,Emergency Treatment ,Factual ,Pediatric ,Emergency Service ,Infant ,Hispanic or Latino ,Health Services ,Length of Stay ,Emergency & Critical Care Medicine ,United States ,crowding ,Socioeconomic Factors ,pediatric admissions ,boarding ,Female ,Patient Safety ,Seasons ,Hispanic Americans ,emergency department length of stay - Abstract
Objective: To estimate the prevalence of and to identify factors associated with prolonged emergency department length-of-stay (ED-LOS) for admitted children. Methods: Data were from the 2001-2006 National Hospital Ambulatory Medical Care Survey. The primary outcome was prolonged ED-LOS (defined as total ED time >8 hours) among admitted children. Predictor variables included patient-level (eg, demographics including race/ethnicity, triage score, diagnosis, and admission to inpatient bed vs intensive care unit), physician-level (intern/resident vs attending physician), and system-level (eg, region, metropolitan area, ED and hospital type, time and season, and diagnostic and therapeutic procedures) factors. Multivariable logistic regression was performed to identify independent predictors of prolonged ED-LOS. Results: Median ED-LOS for admitted children was 3.7 hours. Thirteen percent of pediatric patients admitted from the ED experienced prolonged ED-LOS. Factors associated with prolonged ED-LOS for admitted children were Hispanic ethnicity (odds ratio [OR], 1.76; 95% confidence interval [95% CI], 1.10-2.81), ED arrival between midnight and 8 a.m. (OR, 2.80; 95% CI, 1.87-4.20), winter season (January-March: OR, 1.81; 95% CI, 1.20-2.74), computed tomography scan or magnetic resonance imaging (OR, 1.65; 95% CI, 1.05-2.58), and intravenous fluids or medications (OR, 1.81; 95% CI, 1.10-2.97). Children requiring ICU admissions (OR, 0.29; 95% CI, 0.11-0.77) or receiving pulse oximetry in the ED (OR, 0.52; 95% CI, 0.34-0.81) had a lower risk of experiencing prolonged ED-LOS. Conclusions: We found that prolonged ED-LOS occurs frequently for admitted pediatric patients and is associated with Hispanic ethnicity, presentation during winter season, and early morning arrival. Potential strategies to reduce ED-LOS include improved availability of interpreter services and enhanced staffing and additional inpatient bed availability during winter season and overnight hours. Copyright © 2011 by Lippincott Williams & Wilkins.
- Published
- 2011
5. A national depiction of children with return visits to the emergency department within 72 hours, 2001-2007.
- Author
-
Cho CS, Shapiro DJ, Cabana MD, Maselli JH, and Hersh AL
- Published
- 2012
- Full Text
- View/download PDF
6. Factors associated with prolonged emergency department length of stay for admitted children.
- Author
-
Bekmezian A, Chung PJ, Cabana MD, Maselli JH, Hilton JF, and Hersh AL
- Published
- 2011
- Full Text
- View/download PDF
7. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.
- Author
-
Frymoyer A, Hersh AL, Coralic Z, Benet LZ, and Guglielmo BJ
- Published
- 2010
- Full Text
- View/download PDF
8. "How Sweet the Kill": Orgiastic Female Violence in Contemporary Re-visions of Euripides' The Bacchae
- Author
-
Hersh, Allison
- Published
- 2013
- Full Text
- View/download PDF
9. Decreasing Out-of-pocket Costs of Antibiotics: The Good, the Bad, and the Unknown: Comment on 'Ambulatory Antibiotic Use and Prescription Drug Coverage in Older Adults'.
- Author
-
Hersh AL and Gonzales R
- Published
- 2010
- Full Text
- View/download PDF
10. National trends in visit rates and antibiotic prescribing for adults with acute sinusitis.
- Author
-
Fairlie T, Shapiro DJ, Hersh AL, and Hicks LA
- Published
- 2012
- Full Text
- View/download PDF
11. Changes in prescribing of antiviral medications for influenza associated with new treatment guidelines.
- Author
-
Hersh AL, Maselli JH, and Cabana MD
- Abstract
In 2006, the Centers for Disease Control and Prevention recommended discontinuing the use of adamantanes (amantadine and rimantadine) to treat influenza because of high levels of resistance to this class of antivirals. We examined changes in prescribing practices resulting from this recommendation and found that prescribing of adamantanes declined nationwide, with these drugs accounting for approximately 40% of the antivirals prescribed for influenza from 2000 to 2005 and only 2% in 2006. This finding provides evidence of a rapid change in clinical practice associated with the dissemination of treatment guidelines. Evaluating the effectiveness with which public health recommendations are translated into practice is important given the ongoing emergence of resistance to antiviral drugs and a novel H1N1 influenza virus. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
12. Optimal Pediatric Outpatient Antibiotic Prescribing.
- Author
-
Lehrer BJ, Mutamba G, Thure KA, Evans CD, Hersh AL, Banerjee R, and Katz SE
- Subjects
- Humans, Cross-Sectional Studies, Child, Female, Male, Child, Preschool, Adolescent, Infant, Tennessee, Outpatients statistics & numerical data, Drug Prescriptions statistics & numerical data, Drug Prescriptions standards, Ambulatory Care statistics & numerical data, Inappropriate Prescribing statistics & numerical data, Inappropriate Prescribing prevention & control, Guideline Adherence statistics & numerical data, Anti-Bacterial Agents therapeutic use, Practice Patterns, Physicians' statistics & numerical data, Practice Patterns, Physicians' standards
- Abstract
Importance: In the US, 50% of all pediatric outpatient antibiotics prescribed are unnecessary or inappropriate. Less is known about the appropriateness of pediatric outpatient antibiotic prescribing., Objective: To identify the overall percentage of outpatient antibiotic prescriptions that are optimal according to guideline recommendations for first-line antibiotic choice and duration., Design, Setting, and Participants: This cross-sectional study obtained data on any clinical encounter for a patient younger than 20 years with at least 1 outpatient oral antibiotic, intramuscular ceftriaxone, or penicillin prescription filled in the state of Tennessee from January 1 to December 31, 2022, from IQVIA's Longitudinal Prescription Claims and Medical Claims databases. Each clinical encounter was assigned a single diagnosis corresponding to the lowest applicable tier in a 3-tier antibiotic tier system. Antibiotics prescribed for tier 1 (nearly always required) or tier 2 (sometimes required) diagnoses were compared with published national guidelines. Antibiotics prescribed for tier 3 (rarely ever required) diagnoses were considered to be suboptimal for both choice and duration., Main Outcomes and Measures: Primary outcome was the percentage of optimal antibiotic prescriptions consistent with guideline recommendations for first-line antibiotic choice and duration. Secondary outcomes were the associations of optimal prescribing by diagnosis, suboptimal antibiotic choice, and patient- and clinician-level factors (ie, age and Social Vulnerability Index) with optimal antibiotic choice, which were measured by odds ratios (ORs) and 95% CIs calculated using a multivariable logistic regression model., Results: A total of 506 633 antibiotics were prescribed in 488 818 clinical encounters (for 247 843 females [50.7%]; mean [SD] age, 8.36 [5.5] years). Of these antibiotics, 21 055 (4.2%) were for tier 1 diagnoses, 288 044 (56.9%) for tier 2 diagnoses, and 197 660 (39.0%) for tier 3 diagnoses. Additionally, 194 906 antibiotics (38.5%) were optimal for antibiotic choice, 259 786 (51.3%) for duration, and 159 050 (31.4%) for both choice and duration. Acute otitis media (AOM) and pharyngitis were the most common indications, with 85 635 of 127 312 (67.3%) clinical encounters for AOM and 42 969 of 76 865 (55.9%) clinical encounters for pharyngitis being optimal for antibiotic choice. Only 257 of 4472 (5.7%) antibiotics prescribed for community-acquired pneumonia had a 5-day duration. Optimal antibiotic choice was more likely in patients who were younger (OR, 0.98; 95% CI, 0.98-0.98) and were less socially vulnerable (OR, 0.84; 95% CI, 0.82-0.86)., Conclusions and Relevance: This cross-sectional study found that less than one-third of antibiotics prescribed to pediatric outpatients in Tennessee were optimal for choice and duration. Four stewardship interventions may be targeted: (1) reduce the number of prescriptions for tier 3 diagnoses, (2) increase optimal prescribing for AOM and pharyngitis, (3) provide clinician education on shorter antibiotic treatment courses for community-acquired pneumonia, and (4) promote optimal antibiotic prescribing in resource-limited settings.
- Published
- 2024
- Full Text
- View/download PDF
13. A multicenter randomized trial to compare automatic versus as-needed follow-up for children hospitalized with common infections: The FAAN-C trial protocol.
- Author
-
Coon ER, Greene T, Fritz J, Desai AD, Ray KN, Hersh AL, Bardsley T, Bonafide CP, Brady PW, Wallace SS, and Schroeder AR
- Subjects
- Humans, Child, Preschool, Infant, Child, Patient Discharge, Male, Aftercare, Pneumonia, Female, Follow-Up Studies, Hospitalization
- Abstract
Introduction: Physicians commonly recommend automatic primary care follow-up visits to children being discharged from the hospital. While automatic follow-up provides an opportunity to address postdischarge needs, the alternative is as-needed follow-up. With this strategy, families monitor their child's symptoms and decide if they need a follow-up visit in the days after discharge. In addition to being family centered, as-needed follow-up has the potential to reduce time and financial burdens on both families and the healthcare system. As-needed follow-up has been shown to be safe and effective for children hospitalized with bronchiolitis, but the extent to which hospitalized children with other common conditions might benefit from as-needed follow-up is unclear., Methods: The Follow-up Automatically versus As-Needed Comparison (FAAN-C, or "fancy") trial is a multicenter randomized controlled trial. Children who are hospitalized for pneumonia, urinary tract infection, skin and soft tissue infection, or acute gastroenteritis are eligible to participate. Participants are randomized to an as-needed versus automatic posthospitalization follow-up recommendation. The sample size estimate is 2674 participants and the primary outcome is all-cause hospital readmission within 14 days of discharge. Secondary outcomes are medical interventions and child health-related quality of life. Analyses will be conducted in an intention-to-treat manner, testing noninferiority of as-needed follow-up compared with automatic follow-up., Discussion: FAAN-C will elucidate the relative benefits of an as-needed versus automatic follow-up recommendation, informing one of the most common decisions faced by families of hospitalized children and their medical providers. Findings from FAAN-C will also have implications for national quality metrics and guidelines., (© 2024 Society of Hospital Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
14. Greenhouse gas emissions due to unnecessary antibiotic prescriptions.
- Author
-
Spivak ES, Tobin J, Hersh AL, and Lee AP
- Abstract
Competing Interests: All authors report no conflicts of interest relevant to this article.
- Published
- 2024
- Full Text
- View/download PDF
15. Trends in dexamethasone treatment for asthma in U.S. emergency departments.
- Author
-
Shapiro DJ, Coon ER, Kaiser SV, Grupp-Phelan J, Hersh AL, and Bardach NS
- Published
- 2024
- Full Text
- View/download PDF
16. Antibiotic route and outcomes for children hospitalized with pneumonia.
- Author
-
Cotter JM, Hall M, Neuman MI, Blaschke AJ, Brogan TV, Cogen JD, Gerber JS, Hersh AL, Lipsett SC, Shapiro DJ, and Ambroggio L
- Subjects
- Humans, Retrospective Studies, Male, Female, Child, Child, Preschool, Administration, Oral, Infant, Administration, Intravenous, Hospitalization, Patient Readmission statistics & numerical data, Adolescent, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents administration & dosage, Length of Stay statistics & numerical data, Community-Acquired Infections drug therapy, Pneumonia drug therapy
- Abstract
Background: Emerging evidence suggests that initial oral and intravenous (IV) antibiotics have similar efficacy in pediatric community-acquired pneumonia (CAP), but further data are needed., Objective: We determined the association between hospital-level initial oral antibiotic rates and outcomes in pediatric CAP., Designs, Settings, and Participants: This retrospective cohort study included children hospitalized with CAP at 43 hospitals in the Pediatric Health Information System (2016-2022). Hospitals were grouped by whether initial antibiotics were given orally in a high, moderate, or low proportion of patients., Main Outcome and Measures: Regression models examined associations between high versus low oral-utilizing hospitals and length of stay (LOS, primary outcome), intensive care unit (ICU) transfers, escalated respiratory care, complicated CAP, cost, readmissions, and emergency department (ED) revisits., Results: Initial oral antibiotics were used in 16% (interquartile range: 10%-20%) of 30,207 encounters, ranging from 1% to 68% across hospitals. Comparing high versus low oral-utilizing hospitals (oral rate: 32% [27%-47%] and 10% [9%-11%], respectively), there were no differences in LOS, intensive care unit, complicated CAP, cost, or ED revisits. Escalated respiratory care occurred in 1.3% and 0.5% of high and low oral-utilizing hospitals, respectively (relative ratio [RR]: 2.96 [1.12, 7.81]), and readmissions occurred in 1.5% and 0.8% (RR: 1.68 [1.31, 2.17]). Initial oral antibiotics varied across hospitals without a difference in LOS. While high oral-utilizing hospitals had higher escalated respiratory care and readmission rates, these were rare, the clinical significance of these small differences is uncertain, and there were no differences in other clinically relevant outcomes. This suggests some children may benefit from initial IV antibiotics, but most would probably do well with oral antibiotics., (© 2024 Society of Hospital Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
17. Opportunities to Improve Antibiotic Prescribing for Adults With Acute Sinusitis, United States, 2016-2020.
- Author
-
Vazquez Deida AA, Bizune DJ, Kim C, Sahrmann JM, Sanchez GV, Hersh AL, Butler AM, Hicks LA, and Kabbani S
- Abstract
Background: Better understanding differences associated with antibiotic prescribing for acute sinusitis can help inform antibiotic stewardship strategies. We characterized antibiotic prescribing patterns for acute sinusitis among commercially insured adults and explored differences by patient- and prescriber-level factors., Methods: Outpatient encounters among adults aged 18 to 64 years diagnosed with sinusitis between 2016 and 2020 were identified by national administrative claims data. We classified antibiotic agents-first-line (amoxicillin-clavulanate or amoxicillin) and second-line (doxycycline, levofloxacin, or moxifloxacin)-and ≤7-day durations as guideline concordant based on clinical practice guidelines. Modified Poisson regression was used to examine the association between patient- and prescriber-level factors and guideline-concordant antibiotic prescribing., Results: Among 4 689 850 sinusitis encounters, 53% resulted in a guideline-concordant agent, 30% in a guideline-discordant agent, and 17% in no antibiotic prescription. About 75% of first-line agents and 63% of second-line agents were prescribed for >7 days, exceeding the length of therapy recommended by clinical guidelines. Adults with sinusitis living in a rural area were less likely to receive a prescription with guideline-concordant antibiotic selection (adjusted risk ratio [aRR], 0.92; 95% CI, .92-.92) and duration (aRR, 0.77; 95% CI, .76-.77). When compared with encounters in an office setting, urgent care encounters were less likely to result in a prescription with a guideline-concordant duration (aRR, 0.76; 95% CI, .75-.76)., Conclusions: Opportunities still exist to optimize antibiotic agent selection and treatment duration for adults with acute sinusitis, especially in rural areas and urgent care settings. Recognizing specific patient- and prescriber-level factors associated with antibiotic prescribing can help inform antibiotic stewardship interventions., Competing Interests: Potential conflicts of interest. A. M. B. has received investigator-initiated research funding from Merck on topics unrelated to this work. All other authors report no potential conflicts., (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2024.)
- Published
- 2024
- Full Text
- View/download PDF
18. Excellence in Antibiotic Stewardship: A Mixed-Methods Study Comparing High-, Medium-, and Low-Performing Hospitals.
- Author
-
Vaughn VM, Krein SL, Hersh AL, Buckel WR, White AT, Horowitz JK, Patel PK, Gandhi TN, Petty LA, Spivak ES, Bernstein SJ, Malani AN, Johnson LB, Neetz RA, Flanders SA, Galyean P, Kimball E, Bloomquist K, Zickmund T, Zickmund SL, and Szymczak JE
- Subjects
- Humans, Surveys and Questionnaires, Hospitalists, Inappropriate Prescribing prevention & control, Practice Patterns, Physicians' statistics & numerical data, Antimicrobial Stewardship, Hospitals, Anti-Bacterial Agents therapeutic use, Pharmacists
- Abstract
Background: Despite antibiotic stewardship programs existing in most acute care hospitals, there continues to be variation in appropriate antibiotic use. While existing research examines individual prescriber behavior, contextual reasons for variation are poorly understood., Methods: We conducted an explanatory, sequential mixed-methods study of a purposeful sample of 7 hospitals with varying discharge antibiotic overuse. For each hospital, we conducted surveys, document analysis, and semi-structured interviews with antibiotic stewardship and clinical stakeholders. Data were analyzed separately and mixed during the interpretation phase, where each hospital was examined as a case, with findings organized across cases using a strengths, weaknesses, opportunities, and threats framework to identify factors accounting for differences in antibiotic overuse across hospitals., Results: Surveys included 85 respondents. Interviews included 90 respondents (31 hospitalists, 33 clinical pharmacists, 14 stewardship leaders, 12 hospital leaders). On surveys, clinical pharmacists at hospitals with lower antibiotic overuse were more likely to report feeling: respected by hospitalist colleagues (P = .001), considered valuable team members (P = .001), and comfortable recommending antibiotic changes (P = .02). Based on mixed-methods analysis, hospitals with low antibiotic overuse had 4 distinguishing characteristics: (1) robust knowledge of and access to antibiotic stewardship guidance; (2) high-quality clinical pharmacist-physician relationships; (3) tools and infrastructure to support stewardship; and (4) highly engaged infectious diseases physicians who advocated stewardship principles., Conclusions: This mixed-methods study demonstrates the importance of organizational context for high performance in stewardship and suggests that improving antimicrobial stewardship requires attention to knowledge, interactions, and relationships between clinical teams and infrastructure that supports stewardship and team interactions., Competing Interests: Potential conflicts of interest. S. A. F. reports grants or contracts, paid to institution, from BCBSM and AHRQ, and personal fees from Wiley Publishing. T. N. G. reports grants or contracts paid to institution from BCBSM and AHRQ. L. A. P. reports grants or contracts from BCBSM and AHRQ. W. R. B. reports participation on a data and safety monitoring board or advisory board as scientific advisor for research with The Joint Commission regarding outpatient stewardship. E. S. S. reports grants or contracts with the Centers for Disease Control and Prevention (CDC) Epicenter University of Utah (Matt Samore, principal investigator; author's role is a co-investigator); consulting fees for educational content paid to author from Prime Education LLC; travel expenses paid to the Society for Healthcare Epidemiology of America (SHEA) 2023 and to IDWeek 2022 (speaker). A. H. reports grants or contracts with CDC, AHRQ, and Patient-Centered Outcomes Research Institute, and a leadership or fiduciary role on the Pediatric Infectious Diseases Society Board. A. M. M. has received grant support from and is a physician consultant to the Michigan Department of Health and Human Services, unrelated to the submitted work; has received payment for expert testimony, unrelated to submitted work; was a member of the SHEA Board of Trustees 2020–2022; served as board member of Michigan Infectious Diseases Society; and is a shareholder of Pfizer. V. M. M. reports grants or contracts paid to institution from AHRQ, CDC, National Institutes of Health, and BCBSM. S. L. Z. reports grants or contracts to institution from AHRQ. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
19. Impact of COVID-19 on urgent care diagnoses and the new AXR metric.
- Author
-
Hersh AL, Stenehjem EA, Fino N, and Spivak ES
- Abstract
We examined the antibiotic prescribing rate for respiratory diagnoses (AXR) before and after onset of the COVID-19 pandemic in urgent care clinics. At the onset, AXR declined substantially due to changes in case mix. Using AXR as a stewardship metric requires monitoring of changes in case mix., Competing Interests: All authors report no conflicts of interest relevant to this article., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
20. Antibiotic Stewardship in Outpatient Telemedicine: Adapting Centers for Disease Control and Prevention Core Elements to Optimize Antibiotic Use.
- Author
-
Sanchez GV, Kabbani S, Tsay SV, Bizune D, Hersh AL, Luciano A, and Hicks LA
- Subjects
- United States, Humans, Outpatients, Anti-Bacterial Agents therapeutic use, Centers for Disease Control and Prevention, U.S., Antimicrobial Stewardship, Telemedicine
- Abstract
The rapid expansion of telemedicine has highlighted challenges and opportunities to improve antibiotic use and effectively adapt antibiotic stewardship best practices to outpatient telemedicine settings. Antibiotic stewardship integration into telemedicine is essential to optimize antibiotic prescribing for patients and ensure health care quality. We performed a narrative review of published literature on antibiotic prescribing and stewardship in outpatient telemedicine to inform the adaptation of the Core Elements of Outpatient Antibiotic Stewardship framework to outpatient telemedicine settings. Our narrative review suggests that in-person antibiotic stewardship interventions can be adapted to outpatient telemedicine settings. We present considerations for applying the Core Elements of Outpatient Antibiotic Stewardship to outpatient telemedicine which builds upon growing evidence describing care delivery and quality improvement in this setting. Additional applied implementation research is necessary to inform the application of effective, sustainable, and equitable antibiotic stewardship interventions across the spectrum of outpatient telemedicine.
- Published
- 2024
- Full Text
- View/download PDF
21. Leveraging Health Systems to Expand and Enhance Antibiotic Stewardship in Outpatient Settings.
- Author
-
Rodzik RH, Buckel WR, Hersh AL, Hicks LA, Neuhauser MM, Stenehjem EA, Hyun DY, and Zetts RM
- Subjects
- Humans, Ambulatory Care, Anti-Bacterial Agents therapeutic use, Outpatients, Antimicrobial Stewardship
- Published
- 2024
- Full Text
- View/download PDF
22. Impact of an antibiotic stewardship initiative on urgent-care respiratory prescribing across patient race, ethnicity, and language.
- Author
-
Seibert AM, Hersh AL, Patel PK, Hicks LA, Fino N, Stanfield V, and Stenehjem EA
- Subjects
- Humans, Delivery of Health Care, Anti-Bacterial Agents therapeutic use, Language, Practice Patterns, Physicians', Inappropriate Prescribing prevention & control, Ethnicity, Antimicrobial Stewardship
- Abstract
We conducted a post hoc analysis of an antibiotic stewardship intervention implemented across our health system's urgent-care network to determine whether there was a differential impact among patient groups. Respiratory urgent-care antibiotic prescribing decreased for all racial, ethnic, and preferred language groups, but disparities in antibiotic prescribing persisted.
- Published
- 2024
- Full Text
- View/download PDF
23. Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.
- Author
-
Willis ZI, Oliveira CR, Abzug MJ, Anosike BI, Ardura MI, Bio LL, Boguniewicz J, Chiotos K, Downes K, Grapentine SP, Hersh AL, Heston SM, Hijano DR, Huskins WC, James SH, Jones S, Lockowitz CR, Lloyd EC, MacBrayne C, Maron GM, Hayes McDonough M, Miller CM, Morton TH, Olivero RM, Orscheln RC, Schwenk HT, Singh P, Soma VL, Sue PK, Vora SB, Nakamura MM, and Wolf J
- Subjects
- Adolescent, Child, Humans, Antiviral Agents therapeutic use, Risk Factors, COVID-19 prevention & control, COVID-19 therapy, COVID-19 Drug Treatment, SARS-CoV-2 physiology
- Abstract
Background: Since November 2019, the SARS-CoV-2 pandemic has created challenges for preventing and managing COVID-19 in children and adolescents. Most research to develop new therapeutic interventions or to repurpose existing ones has been undertaken in adults, and although most cases of infection in pediatric populations are mild, there have been many cases of critical and fatal infection. Understanding the risk factors for severe illness and the evidence for safety, efficacy, and effectiveness of therapies for COVID-19 in children is necessary to optimize therapy., Methods: A panel of experts in pediatric infectious diseases, pediatric infectious diseases pharmacology, and pediatric intensive care medicine from 21 geographically diverse North American institutions was re-convened. Through a series of teleconferences and web-based surveys and a systematic review with meta-analysis of data for risk factors, a guidance statement comprising a series of recommendations for risk stratification, treatment, and prevention of COVID-19 was developed and refined based on expert consensus., Results: There are identifiable clinical characteristics that enable risk stratification for patients at risk for severe COVID-19. These risk factors can be used to guide the treatment of hospitalized and non-hospitalized children and adolescents with COVID-19 and to guide preventative therapy where options remain available., (© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
24. Interventions to de-implement unnecessary antibiotic prescribing for ear infections (DISAPEAR Trial): protocol for a cluster-randomized trial.
- Author
-
Jenkins TC, Keith A, Stein AB, Hersh AL, Narayan R, Eggleston A, Rinehart DJ, Patel PK, Walter E, Hargraves IG, and Frost HM
- Subjects
- Child, Humans, Ambulatory Care Facilities, Anti-Bacterial Agents therapeutic use, Electronic Health Records, Randomized Controlled Trials as Topic, Otitis, Antimicrobial Stewardship
- Abstract
Background: Watchful waiting management for acute otitis media (AOM), where an antibiotic is used only if the child's symptoms worsen or do not improve over the subsequent 2-3 days, is an effective approach to reduce antibiotic exposure for children with AOM. However, studies to compare the effectiveness of interventions to promote watchful waiting are lacking. The objective of this study is to compare the effectiveness and implementation outcomes of two pragmatic, patient-centered interventions designed to facilitate use of watchful waiting in clinical practice., Methods: This will be a cluster-randomized trial utilizing a hybrid implementation-effectiveness design. Thirty-three primary care or urgent care clinics will be randomized to one of two interventions: a health systems-level intervention alone or a health systems-level intervention combined with use of a shared decision-making aid. The health systems-level intervention will include engagement of a clinician champion at each clinic, changes to electronic health record antibiotic orders to facilitate delayed antibiotic prescriptions as part of a watchful waiting strategy, quarterly feedback reports detailing clinicians' use of watchful waiting individually and compared with peers, and virtual learning sessions for clinicians. The hybrid intervention will include the health systems-level intervention plus a shared decision-making aid designed to inform decision-making between parents and clinicians with best available evidence. The primary outcomes will be whether an antibiotic was ultimately taken by the child and parent satisfaction with their child's care. We will explore the differences in implementation effectiveness by patient population served, clinic type, clinical setting, and organization. The fidelity, acceptability, and perceived appropriateness of the interventions among different clinician types, patient populations, and clinical settings will be compared. We will also conduct formative qualitative interviews and surveys with clinicians and administrators, focus groups and surveys of parents of patients with AOM, and engagement of two stakeholder advisory councils to further inform the interventions., Discussion: This study will compare the effectiveness of two pragmatic interventions to promote use of watchful waiting for children with AOM to reduce antibiotic exposure and increase parent satisfaction, thus informing national antibiotic stewardship policy development., Clinical Trial Registration: NCT06034080., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
25. Comparison of antibiotic prescribing between physicians and advanced practice clinicians.
- Author
-
Hersh AL, Shapiro DJ, Sanchez GV, and Hicks LA
- Subjects
- Humans, Anti-Bacterial Agents therapeutic use, Practice Patterns, Physicians', Inappropriate Prescribing prevention & control, Respiratory Tract Infections drug therapy, Physicians, Medicine
- Abstract
We compared antibiotic prescribing rates for respiratory conditions in a national sample of outpatient visits from 2010 to 2018 between physicians and advanced practice clinicians (APCs). APCs prescribed antibiotics more frequently than physicians (58% vs 52%), but there were no differences in selection of guideline recommended first-line agents between specialties.
- Published
- 2024
- Full Text
- View/download PDF
26. Next Steps in Ambulatory Stewardship.
- Author
-
Frost HM, Hersh AL, and Hyun DY
- Abstract
Most antibiotics are prescribed in ambulatory setting and at least 30% to 50% of these prescriptions are unnecessary. The use of antibiotics when not needed promotes the development of antibiotic resistant organisms and harms patients by placing them at risk for adverse drug events and Clostridioides difficile infections. National guidelines recommend that health systems implement antibiotic stewardship programs in ambulatory settings. However, uptake of stewardship in ambulatory setting has remained low. This review discusses the current state of ambulatory stewardship in the United States, best practices for the successful implementation of effective ambulatory stewardship programs, and future directions to improve antibiotic use in ambulatory settings., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
27. Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline.
- Author
-
Ambroggio L, Cotter J, Hall M, Shapiro DJ, Lipsett SC, Hersh AL, Shah SS, Brogan TV, Gerber JS, Williams DJ, Blaschke AJ, Cogen JD, and Neuman MI
- Subjects
- Child, Humans, Pandemics, Anti-Bacterial Agents therapeutic use, Emergency Service, Hospital, Penicillins therapeutic use, Guideline Adherence, Retrospective Studies, Pneumonia diagnosis, Pneumonia drug therapy, Pneumonia epidemiology, Communicable Diseases drug therapy, COVID-19, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology
- Abstract
Background: Incomplete uptake of guidelines can lead to nonstandardized care, increased expenditures, and adverse clinical outcomes. The objective of this study was to evaluate the impact of the 2011 Pediatric Infectious Diseases Society and Infectious Diseases Society of America (PIDS/IDSA) pediatric community-acquired pneumonia (CAP) guideline that emphasized aminopenicillin use and de-emphasized the use of chest radiographs (CXRs) in certain populations., Methods: This quasi-experimental study queried a national administrative database of children's hospitals to identify children aged 3 months-18 years with CAP who visited 1 of 28 participating hospitals from 2009 to 2021. PIDS/IDSA pediatric CAP guideline recommendations regarding antibiotic therapy, diagnostic testing, and imaging were evaluated. Segmented regression interrupted time series was used to measure guideline-concordant practices with interruptions for guideline publication and the Coronavirus Disease 2019 (COVID-19) pandemic., Results: Of 315 384 children with CAP, 71 804 (22.8%) were hospitalized. Among hospitalized children, there was a decrease in blood culture performance (0.5% per quarter) and increase in aminopenicillin prescribing (1.1% per quarter). Among children discharged from the emergency department (ED), there was an increase in aminopenicillin prescription (0.45% per quarter), whereas the rate of obtaining CXRs declined (0.12% per quarter). However, use of CXRs rebounded during the COVID-19 pandemic (increase of 1.56% per quarter). Hospital length of stay, ED revisit rates, and hospital readmission rates remained stable., Conclusions: Guideline publication was associated with an increase of aminopenicillin prescribing. However, rates of diagnostic testing did not materially change, suggesting the need to consider implementation strategies to meaningfully change clinical practice for children with CAP., Competing Interests: Potential conflicts of interest. L. A.'s institution receives funding from Pfizer Inc on her behalf for an unrelated study and also reports support from the National Institute of Allergy and Infectious Diseases, unrelated to this work (grant numbers K01AI125413 and R21AI154239). D. J. S. reports a grant or contract from the Agency for Healthcare Quality and Research, unrelated to this work (T32HS000063-28). J. C. reports grants or contracts unrelated to this work from Pfizer Inc. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
28. National Patterns of Outpatient Follow-Up Visits After Emergency Care for Acute Bronchiolitis.
- Author
-
Shapiro DJ, Bourgeois FT, Fine AM, Hersh AL, Coon ER, Neuman MI, and Wu AC
- Subjects
- Humans, Follow-Up Studies, Outpatients, Emergency Service, Hospital, Emergency Medical Services, Bronchiolitis epidemiology, Bronchiolitis therapy
- Published
- 2023
- Full Text
- View/download PDF
29. Beyond antibiotic prescribing rates: first-line antibiotic selection, prescription duration, and associated factors for respiratory encounters in urgent care.
- Author
-
Seibert AM, Schenk C, Buckel WR, Patel PK, Fino N, Stanfield V, Hersh AL, and Stenehjem E
- Abstract
Objective: Assess urgent care (UC) clinician prescribing practices and factors associated with first-line antibiotic selection and recommended duration of therapy for sinusitis, acute otitis media (AOM), and pharyngitis., Design: Retrospective cohort study., Participants: All respiratory UC encounters and clinicians in the Intermountain Health (IH) network, July 1st, 2019-June 30th, 2020., Methods: Descriptive statistics were used to characterize first-line antibiotic selection rates and the duration of antibiotic prescriptions during pharyngitis, sinusitis, and AOM UC encounters. Patient and clinician characteristics were evaluated. System-specific guidelines recommended 5-10 days of penicillin, amoxicillin, or amoxicillin-clavulanate as first-line. Alternative therapies were recommended for penicillin allergy. Generalized estimating equation modeling was used to assess predictors of first-line antibiotic selection, prescription duration, and first-line antibiotic prescriptions for an appropriate duration., Results: Among encounters in which an antibiotic was prescribed, the rate of first-line antibiotic selection was 75%, the recommended duration was 70%, and the rate of first-line antibiotic selection for the recommended duration was 53%. AOM was associated with the highest rate of first-line prescriptions (83%); sinusitis the lowest (69%). Pharyngitis was associated with the highest rate of prescriptions for the recommended duration (91%); AOM the lowest (51%). Penicillin allergy was the strongest predictor of non-first-line selection (OR = 0.02, 95% CI [0.02, 0.02]) and was also associated with extended duration prescriptions (OR = 0.87 [0.80, 0.95])., Conclusions: First-line antibiotic selection and duration for respiratory UC encounters varied by diagnosis and patient characteristics. These areas can serve as a focus for ongoing stewardship efforts., (© The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF
30. Patterns of Outpatient Follow-up Visits After Hospitalizations for Acute Bronchiolitis.
- Author
-
Shapiro DJ, Wu AC, Hersh AL, and Coon ER
- Subjects
- Humans, Follow-Up Studies, Hospitalization, Risk Factors, Emergency Service, Hospital, Retrospective Studies, Outpatients, Bronchiolitis therapy
- Published
- 2023
- Full Text
- View/download PDF
31. Preliminary Reach of an Information Technology Approach to Support COVID-19 Testing in Schools.
- Author
-
Stump TK, Wetter DW, Kuzmenko T, Orleans B, Kolp L, Wirth J, Del Fiol G, Chipman J, Haaland B, Kaphingst KA, Hersh AL, and Wu YP
- Subjects
- Child, Humans, Information Technology, COVID-19 Testing, Schools, COVID-19 diagnosis, Text Messaging
- Abstract
Objectives: SCALE-UP Counts tests population health management interventions to promote coronavirus disease 2019 (COVID-19) testing in kindergarten through 12th-grade schools that serve populations that have been historically marginalized., Methods: Within 6 participating schools, we identified 3506 unique parents/guardians who served as the primary contact for at least 1 student. Participants were randomized to text messaging (TM), text messaging + health navigation (HN) (TM + HN), or usual care. Bidirectional texts provided COVID-19 symptom screening, along with guidance on obtaining and using tests as appropriate. If parents/guardians in the TM + HN group were advised to test their child but either did not test or did not respond to texts, they were called by a trained health navigator to address barriers., Results: Participating schools served a student population that was 32.9% non-white and 15.4% Hispanic, with 49.6% of students eligible to receive free lunches. Overall, 98.8% of parents/guardians had a valid cell phone, of which 3.8% opted out. Among the 2323 parents/guardians included in the intervention, 79.6% (n = 1849) were randomized to receive TM, and 19.1% (n = 354) engaged with TM (ie, responded to at least 1 message). Within the TM + HN group (40.1%, n = 932), 1.3% (n = 12) qualified for HN at least once, of which 41.7% (n = 5) talked to a health navigator., Conclusions: TM and HN are feasible ways to reach parents/guardians of kindergarten through 12th-grade students to provide COVID-19 screening messages. Strategies to improve engagement may strengthen the impact of the intervention., (Copyright © 2023 by the American Academy of Pediatrics.)
- Published
- 2023
- Full Text
- View/download PDF
32. Pediatric infectious disease physician perceptions of antimicrobial stewardship programs.
- Author
-
Lake JG, Durkin MJ, Polgreen PM, Beekmann SE, Hersh AL, and Newland JG
- Subjects
- Humans, Child, Anti-Bacterial Agents therapeutic use, Surveys and Questionnaires, Antimicrobial Stewardship, Physicians, Communicable Diseases drug therapy
- Abstract
Pediatric antimicrobial stewardship programs (ASPs) improve antibiotic use for hospitalized children. Prescriber surveys indicate acceptance of ASPs, but data on infectious diseases (ID) physician opinions of ASPs are lacking. We conducted a survey of pediatric ID physicians, ASP and non-ASP, and their perceptions of ASP practices and outcomes.
- Published
- 2023
- Full Text
- View/download PDF
33. Notes from the Field: Update on Pediatric Intracranial Infections - 19 States and the District of Columbia, January 2016-March 2023.
- Author
-
Accorsi EK, Hall M, Hersh AL, Shah SS, Schrag SJ, and Cohen AL
- Subjects
- Humans, Child, United States epidemiology, District of Columbia, Population Surveillance
- Abstract
Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Adam L. Cohen reports travel support from the World Health Organization for attending meetings. Adam L. Hersh reports grants or contracts from the Agency for Health Research and Quality, participation on the National Institutes of Health Data and Safety Monitoring Board, and leadership or fiduciary roles in the Pediatric Infectious Diseases Society. Samir S. Shah reports institutional grant support from the Children’s Hospital Association, textbook royalties from McGraw Hill Education, Wolters Kluwer, and Elsevier, and honoraria from the Society of Hospital Medicine for work as the Editor-in-Chief of the Journal of Hospital Medicine. No other potential conflicts of interest were disclosed.
- Published
- 2023
- Full Text
- View/download PDF
34. Exploring unintended consequences of adult antimicrobial stewardship programs: An Emerging Infections Network survey.
- Author
-
Durkin MJ, Lake J, Polgreen PM, Beekmann SE, Hersh AL, and Newland JG
- Subjects
- Humans, Adult, Surveys and Questionnaires, Antimicrobial Stewardship, Physicians
- Abstract
We performed a survey of adult infectious diseases (ID) physicians to explore unintended consequences of antimicrobial stewardship programs (ASP). ID physicians worried about disagreement with colleagues, provider autonomy, and remote recommendations. Non-ASP ID physicians expressed more concern regarding ASPs focus on costs, provider efficiency, and unintended consequences of ASP guidance.
- Published
- 2023
- Full Text
- View/download PDF
35. Implementation of an Antibiotic Stewardship Initiative in a Large Urgent Care Network.
- Author
-
Stenehjem E, Wallin A, Willis P, Kumar N, Seibert AM, Buckel WR, Stanfield V, Brunisholz KD, Fino N, Samore MH, Srivastava R, Hicks LA, and Hersh AL
- Subjects
- Humans, Female, Adult, Male, Anti-Bacterial Agents therapeutic use, Ambulatory Care, Respiratory Tract Infections drug therapy, Antimicrobial Stewardship, Sinusitis drug therapy
- Abstract
Importance: Urgent Care (UC) encounters result in more inappropriate antibiotic prescriptions than other outpatient setting. Few stewardship interventions have focused on UC., Objective: To evaluate the effectiveness of an antibiotic stewardship initiative to reduce antibiotic prescribing for respiratory conditions in a UC network., Design, Setting, and Participants: This quality improvement study conducted in a UC network with 38 UC clinics and 1 telemedicine clinic included 493 724 total UC encounters. The study compared the antibiotic prescribing rates of all UC clinicians who encountered respiratory conditions for a 12-month baseline period (July 1, 2018, through June 30, 2019) with an intervention period (July 1, 2019, through June 30, 2020). A sustainability period (July 1, 2020, through June 30, 2021) was added post hoc., Interventions: Stewardship interventions included (1) education for clinicians and patients, (2) electronic health record (EHR) tools, (3) a transparent clinician benchmarking dashboard, and (4) media. Occurring independently but concurrent with the interventions, a stewardship measure was introduced by UC leadership into the quality measures, including a financial incentive., Main Outcomes and Measures: The primary outcome was the percentage of UC encounters with an antibiotic prescription for a respiratory condition. Secondary outcomes included antibiotic prescribing when antibiotics were not indicated (tier 3 encounters) and first-line antibiotics for acute otitis media, sinusitis, and pharyngitis. Interrupted time series with binomial generalized estimating equations were used to compare periods., Results: The baseline period included 207 047 UC encounters for respiratory conditions (56.8% female; mean [SD] age, 30.0 [21.4] years; 92.0% White race); the intervention period included 183 893 UC encounters (56.4% female; mean [SD] age, 30.7 [20.8] years; 91.2% White race). Antibiotic prescribing for respiratory conditions decreased from 47.8% (baseline) to 33.3% (intervention). During the initial intervention month, a 22% reduction in antibiotic prescribing occurred (odds ratio [OR], 0.78; 95% CI, 0.71-0.86). Antibiotic prescriptions decreased by 5% monthly during the intervention (OR, 0.95; 95% CI, 0.94-0.96). Antibiotic prescribing for tier 3 encounters decreased by 47% (OR, 0.53; 95% CI, 0.44-63), and first-line antibiotic prescriptions increased by 18% (OR, 1.18; 95% CI, 1.09-1.29) during the initial intervention month. Antibiotic prescriptions for tier 3 encounters decreased by an additional 4% each month (OR, 0.96; 95% CI, 0.94-0.98), whereas first-line antibiotic prescriptions did not change (OR, 1.00; 95% CI, 0.99-1.01). Antibiotic prescribing for respiratory conditions remained stable in the sustainability period., Conclusions and Relevance: The findings of this quality improvement study indicated that a UC antibiotic stewardship initiative was associated with decreased antibiotic prescribing for respiratory conditions. This study provides a model for UC antibiotic stewardship.
- Published
- 2023
- Full Text
- View/download PDF
36. Pharmacist gender and physician acceptance of antibiotic stewardship recommendations: An analysis of the reducing overuse of antibiotics at discharge home intervention.
- Author
-
Vaughn VM, Giesler DL, Mashrah D, Brancaccio A, Sandison K, Spivak ES, Szymczak JE, Wu C, Horowitz JK, Bashaw L, and Hersh AL
- Subjects
- Humans, Male, Female, Pharmacists, Anti-Bacterial Agents therapeutic use, Patient Discharge, Retrospective Studies, Sexism, Antimicrobial Stewardship, Hospitalists
- Abstract
Objective: To assess association of pharmacist gender with acceptance of antibiotic stewardship recommendations., Design: A retrospective evaluation of the Reducing Overuse of Antibiotics at Discharge (ROAD) Home intervention., Setting: The study was conducted from May to October 2019 in a single academic medical center., Participants: The study included patients receiving antibiotics on a hospitalist service who were nearing discharge., Methods: During the intervention, clinical pharmacists (none who had specialist postgraduate infectious disease residency training) reviewed patients on antibiotics and led an antibiotic timeout (ie, structured conversation) prior to discharge to improve discharge antibiotic prescribing. We assessed the association of pharmacist gender with acceptance of timeout recommendations by hospitalists using logistic regression controlling for patient characteristics., Results: Over 6 months, pharmacists conducted 295 timeouts: 158 timeouts (53.6%) were conducted by 12 women, 137 (46.4%) were conducted by 8 men. Pharmacists recommended an antibiotic change in 82 timeouts (27.8%), of which 51 (62.2%) were accepted. Compared to male pharmacists, female pharmacists were less likely to recommend a discharge antibiotic change: 30 (19.0%) of 158 versus 52 (38.0%) of 137 (P < .001). Female pharmacists were also less likely to have a recommendation accepted: 10 (33.3%) of 30 versus 41 (8.8%) of 52 (P < .001). Thus, timeouts conducted by female versus male pharmacists were less likely to result in an antibiotic change: 10 (6.3%) of 158 versus 41 (29.9%) of 137 (P < .001). After adjustments, pharmacist gender remained significantly associated with whether recommended changes were accepted (adjusted odds ratio [aOR], 0.10; 95%confidence interval [CI], 0.03-0.36 for female versus male pharmacists)., Conclusions: Antibiotic stewardship recommendations made by female clinical pharmacists were less likely to be accepted by hospitalists. Gender bias may play a role in the acceptance of clinical pharmacist recommendations, which could affect patient care and outcomes.
- Published
- 2023
- Full Text
- View/download PDF
37. Antibiotics and outcomes of CF pulmonary exacerbations in children infected with MRSA and Pseudomonas aeruginosa.
- Author
-
Cogen JD, Hall M, Faino AV, Ambroggio L, Blaschke AJ, Brogan TV, Cotter JM, Gibson RL, Grijalva CG, Hersh AL, Lipsett SC, Shah SS, Shapiro DJ, Neuman MI, and Gerber JS
- Subjects
- Humans, Child, Anti-Bacterial Agents therapeutic use, Pseudomonas aeruginosa, Prospective Studies, Retrospective Studies, Methicillin-Resistant Staphylococcus aureus, Cystic Fibrosis complications, Cystic Fibrosis drug therapy, Pseudomonas Infections diagnosis, Pseudomonas Infections drug therapy, Pseudomonas Infections complications
- Abstract
Background: Limited data exist to inform antibiotic selection among people with cystic fibrosis (CF) with airway infection by multiple CF-related microorganisms. This study aimed to determine among children with CF co-infected with methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (Pa) if the addition of anti-MRSA antibiotics to antipseudomonal antibiotic treatment for pulmonary exacerbations (PEx) would be associated with improved clinical outcomes compared with antipseudomonal antibiotics alone., Methods: Retrospective cohort study using data from the CF Foundation Patient Registry-Pediatric Health Information System linked dataset. The odds of returning to baseline lung function and having a subsequent PEx requiring intravenous antibiotics were compared between PEx treated with anti-MRSA and antipseudomonal antibiotics and those treated with antipseudomonal antibiotics alone, adjusting for confounding by indication using inverse probability of treatment weighting., Results: 943 children with CF co-infected with MRSA and Pa contributed 2,989 PEx for analysis. Of these, 2,331 (78%) PEx were treated with both anti-MRSA and antipseudomonal antibiotics and 658 (22%) PEx were treated with antipseudomonal antibiotics alone. Compared with PEx treated with antipseudomonal antibiotics alone, the addition of anti-MRSA antibiotics to antipseudomonal antibiotic therapy was not associated with a higher odds of returning to ≥90% or ≥100% of baseline lung function or a lower odds of future PEx requiring intravenous antibiotics., Conclusions: Children with CF co-infected with MRSA and Pa may not benefit from the addition of anti-MRSA antibiotics for PEx treatment. Prospective studies evaluating optimal antibiotic selection strategies for PEx treatment are needed to optimize clinical outcomes following PEx treatment., Competing Interests: Declaration of Competing Interest Drs. Cogen and Ms. Faino received support from the Cystic Fibrosis Foundation (COGEN19A0) Dr. Gibson received support from the Cystic Fibrosis Foundation (GIBSON1R0) Drs. Hall, Ambroggio, Blaschke, Brogan, Cotter, Grijalva, Hersh, Lipsett, Shah, Shapiro, Neuman and Gerber have nothing to disclose at it relates to this manuscript., (Copyright © 2022 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
38. Validity of Coronavirus Disease 2019 International Classification of Diseases, Tenth Revision in the Urgent Care Setting and Impact on Antibiotic Prescribing Rates.
- Author
-
Medvedeva N, Ong'uti S, Hersh AL, Chang A, Mui E, Stenehjem E, Ha D, and Holubar M
- Abstract
We validated different coronavirus disease 2019 (COVID-19) International Classification of Diseases, Tenth Edition (ICD-10) encounter definitions across 2 urgent care clinics. Sensitivity of definitions varied throughout the pandemic. Inclusion of COVID-19 and COVID-19-like illness (CLI) ICD-10s rendered highest sensitivity but lowest specificity. Antibiotic prescribing rates were low for COVID-19 ICD-10 encounters, increasing with CLI ICD-10 encounters., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2023
- Full Text
- View/download PDF
39. Characteristics of antifungal utilization for hospitalized children in the United States.
- Author
-
Eguiguren L, Lee BR, Newland JG, Kronman MP, Hersh AL, Gerber JS, Lee GM, and Schwenk HT
- Abstract
Objective: To characterize antifungal prescribing patterns, including the indication for antifungal use, in hospitalized children across the United States., Design: We analyzed antifungal prescribing data from 32 hospitals that participated in the SHARPS Antibiotic Resistance, Prescribing, and Efficacy among Children (SHARPEC) study, a cross-sectional point-prevalence survey conducted between June 2016 and December 2017., Methods: Inpatients aged <18 years with an active systemic antifungal order were included in the analysis. We classified antifungal prescribing by indication (ie, prophylaxis, empiric, targeted), and we compared the proportion of patients in each category based on patient and antifungal characteristics., Results: Among 34,927 surveyed patients, 2,095 (6%) received at least 1 systemic antifungal and there were 2,207 antifungal prescriptions. Most patients had an underlying oncology or bone marrow transplant diagnosis (57%) or were premature (13%). The most prescribed antifungal was fluconazole (48%) and the most common indication for antifungal use was prophylaxis (64%). Of 2,095 patients receiving antifungals, 79 (4%) were prescribed >1 antifungal, most often as targeted therapy (48%). The antifungal prescribing rate ranged from 13.6 to 131.2 antifungals per 1,000 patients across hospitals ( P < .001)., Conclusions: Most antifungal use in hospitalized children was for prophylaxis, and the rate of antifungal prescribing varied significantly across hospitals. Potential targets for antifungal stewardship efforts include high-risk, high-utilization populations, such as oncology and bone marrow transplant patients, and specific patterns of utilization, including prophylactic and combination antifungal therapy., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
40. Amoxicillin Versus Other Antibiotic Agents for the Treatment of Acute Otitis Media in Children.
- Author
-
Frost HM, Bizune D, Gerber JS, Hersh AL, Hicks LA, and Tsay SV
- Subjects
- Child, Humans, Infant, Azithromycin therapeutic use, Cefdinir, Retrospective Studies, Acute Disease, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Amoxicillin-Potassium Clavulanate Combination therapeutic use, Amoxicillin therapeutic use, Otitis Media drug therapy, Otitis Media microbiology
- Abstract
Objectives: The objective of the study was to compare the antibiotic treatment failure and recurrence rates between antibiotic agents (amoxicillin, amoxicillin-clavulanate, cefdinir, and azithromycin) for children with uncomplicated acute otitis media (AOM)., Study Design: We completed a retrospective cohort study of children 6 months-12 years of age with uncomplicated AOM identified in a nationwide claims database. The primary exposure was the antibiotic agent, and the primary outcomes were treatment failure and recurrence. Logistic regression was used to estimate ORs, and analyses were stratified by primary exposure, patient age, and antibiotic duration., Results: Among the 1 051 007 children included in the analysis, 56.6% were prescribed amoxicillin, 13.5% were prescribed amoxicillin-clavulanate, 20.6% were prescribed cefdinir, and 9.3% were prescribed azithromycin. Most prescriptions (93%) were for 10 days, and 98% were filled within 1 day of the medical encounter. Treatment failure and recurrence occurred in 2.2% (95% CI: 2.1, 2.2) and 3.3% (3.2, 3.3) of children, respectively. Combined failure and recurrence rates were low for all agents including amoxicillin (1.7%; 1.7, 1.8), amoxicillin-clavulanate (11.3%; 11.1, 11.5), cefdinir (10.0%; 9.8, 10.1), and azithromycin (9.8%; 9.6, 10.0)., Conclusions: Despite microbiologic changes in AOM etiology, treatment failure and recurrence were uncommon for all antibiotic agents and were lower for amoxicillin than for other agents. These findings support the continued use of amoxicillin as a first-line agent for AOM when antibiotics are prescribed., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
41. Harnessing the Power of Health Systems and Networks for Antimicrobial Stewardship.
- Author
-
Buckel WR, Stenehjem EA, Hersh AL, Hyun DY, and Zetts RM
- Subjects
- Humans, Anti-Bacterial Agents therapeutic use, Surveys and Questionnaires, Antimicrobial Stewardship
- Abstract
Twenty of 21 health systems and network-based antimicrobial stewardship programs (ASPs) who were invited participated in a questionnaire, a webinar, and focus groups to understand implementation strategies for system-wide antimicrobial stewardship. Four centralized ASPs structures emerged. Of participating organizations, 3 (15%) confirmed classification as collaborative, 3 (15%) as centrally coordinated, 3 (15%) as in between or in transition between centrally coordinated and centrally led, 8 (40%) as centrally led, 2 (10%) as collaborative, consultative network. One (5%) organization considered themselves to be a hybrid. System-level stewardship responsibilities varied across sites and generally fell into 6 major categories: building and leading a stewardship community, strategic planning and goal setting, development of validated data streams, leveraging tools and technology for stewardship interventions, provision of subject-matter expertise, and communication/education. Centralized ASPs included in this study most commonly took a centrally led approach and engaged in activities tailored to system-wide goals., Competing Interests: Potential conflicts of interest. A. H. reports grants or contracts from the Centers for Disease Control and Prevention (CDC), EHRQ, and NIHPe all outside of the submitted work; participation on a Data Safety Monitoring Board or Advisory Board for National Institutes of Health (NIH); and leadership or fiduciary role for Pediatric Infectious Disease Society. E. S. reports grants or contracts from CDC – SHEPHERD, CDC – Vision, and CDC – Epicenter all outside of the submitted work. W. R. B. reports leadership or fiduciary role for Society for Healthcare Epidemiology of America. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2022
- Full Text
- View/download PDF
42. Urgent-care antibiotic prescribing: An exploratory analysis to evaluate health inequities.
- Author
-
Seibert AM, Hersh AL, Patel PK, Matheu M, Stanfield V, Fino N, Hicks LA, Tsay SV, Kabbani S, and Stenehjem E
- Abstract
Healthcare disparities and inequities exist in a variety of environments and manifest in diagnostic and therapeutic measures. In this commentary, we highlight our experience examining our organization's urgent care respiratory encounter antibiotic prescribing practices. We identified differences in prescribing based on several individual characteristics including patient age, race, ethnicity, preferred language, and patient and/or clinician gender. Our approach can serve as an electronic health record (EHR)-based methodology for disparity and inequity audits in other systems and for other conditions., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
43. Pediatric antimicrobial stewardship practices at discharge: A national survey.
- Author
-
Wang ME, Felder K, Newland JG, Hersh AL, Rajapakse NS, Willis ZI, Banerjee R, Gerber JS, Schwenk HT, and Vaz LE
- Subjects
- Child, Humans, Patient Discharge, Anti-Bacterial Agents therapeutic use, Prescriptions, Antimicrobial Stewardship, Anti-Infective Agents
- Abstract
We surveyed pediatric antimicrobial stewardship program (ASP) site leaders within the Sharing Antimicrobial Reports for Pediatric Stewardship collaborative regarding discharge stewardship practices. Among 67 sites, 13 (19%) reported ASP review of discharge antimicrobial prescriptions. These findings highlight discharge stewardship as a potential opportunity for improvement during the hospital-to-home transition.
- Published
- 2022
- Full Text
- View/download PDF
44. A Veterans' Healthcare Administration (VHA) antibiotic stewardship intervention to improve outpatient antibiotic use for acute respiratory infections: A cost-effectiveness analysis.
- Author
-
Yoo M, Madaras-Kelly K, Nevers M, Fleming-Dutra KE, Hersh AL, Ying J, Haaland B, Samore M, and Nelson RE
- Subjects
- Humans, Cost-Benefit Analysis, Anti-Bacterial Agents therapeutic use, Outpatients, Delivery of Health Care, Antimicrobial Stewardship, Veterans, Respiratory Tract Infections drug therapy
- Abstract
Objectives: The Core Elements of Outpatient Antibiotic Stewardship provides a framework to improve antibiotic use, but cost-effectiveness data on implementation of outpatient antibiotic stewardship interventions are limited. We evaluated the cost-effectiveness of Core Element implementation in the outpatient setting., Methods: An economic simulation model from the health-system perspective was developed for patients presenting to outpatient settings with uncomplicated acute respiratory tract infections (ARI). Effectiveness was measured as quality-adjusted life years (QALYs). Cost and utility parameters for antibiotic treatment, adverse drug events (ADEs), and healthcare utilization were obtained from the literature. Probabilities for antibiotic treatment and appropriateness, ADEs, hospitalization, and return ARI visits were estimated from 16,712 and 51,275 patient visits in intervention and control sites during the pre- and post-implementation periods, respectively. Data for materials and labor to perform the stewardship activities were used to estimate intervention cost. We performed a one-way and probabilistic sensitivity analysis (PSA) using 1,000,000 second-order Monte Carlo simulations on input parameters., Results: The proportion of ARI patient-visits with antibiotics prescribed in intervention sites was lower (62% vs 74%) and appropriate treatment higher (51% vs 41%) after implementation, compared to control sites. The estimated intervention cost over a 2-year period was $133,604 (2018 US dollars). The intervention had lower mean costs ($528 vs $565) and similar mean QALYs (0.869 vs 0.868) per patient compared to usual care. In the PSA, the intervention was dominant in 63% of iterations., Conclusions: Implementation of the CDC Core Elements in the outpatient setting was a cost-effective strategy.
- Published
- 2022
- Full Text
- View/download PDF
45. Outpatient antimicrobial stewardship programs in pediatric institutions in 2020: Status, needs, barriers.
- Author
-
El Feghaly RE, Monsees EA, Burns A, Wirtz A, Lee BR, Hersh AL, and Newland JG
- Subjects
- Humans, Child, Outpatients, Cross-Sectional Studies, Anti-Bacterial Agents therapeutic use, Antimicrobial Stewardship, Anti-Infective Agents
- Abstract
Objective: To assess current resources, interventions, and obstacles of pediatric outpatient antimicrobial stewardship programs (ASP)., Design: Cross-sectional study., Setting: Institutions from the Sharing Antimicrobial Reports for Pediatric Stewardship OutPatient collaborative (SHARPS-OP)., Participants: Antimicrobial stewardship leaders from the above institutions., Methods: An investigator-developed survey was deployed online in September 2020 to antimicrobial stewardship leaders in SHARPS-OP institutions. The survey was divided into 4 sections: (1) basic information, (2) status of pediatric outpatient ASP in the institutions including financial support, (3) outpatient ASP interventions undertaken by the institutions, and (4) needs and SHARPS-OP collaborative goals., Results: Of 56 invited institutions, 45 participated, achieving an 80% response rate. Only 5 sites (11%) had allocated financial support for an outpatient ASP, compared to 42 (95.6%) for their inpatient ASP. The most widely used outpatient ASP interventions included antimicrobial guidance (57.8%), education (46.7%), and quality improvement projects (37.8%). Time was identified as the biggest barrier to expanding outpatient ASPs (91.1%), followed by financial support (53.3%), development of meaningful reports (51.1%), and administrative support (44.4%). Important goals of the collaborative included seeking learning opportunities and developing clear metrics for pediatric outpatient ASP benchmarking. Program needs included securing operational support (35.8%) and strengthening data analysis (31.6%)., Conclusions: Very few pediatric institutions with robust inpatient ASPs have devoted time and financial support to advance outpatient efforts. To promote appropriate antibiotic prescribing in the outpatient arena, time and resource funding by administrative leaders are necessary to develop a robust, sustainable stewardship infrastructure.
- Published
- 2022
- Full Text
- View/download PDF
46. Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
- Author
-
Vaughn VM, Ratz D, Greene MT, Flanders SA, Gandhi TN, Petty LA, Huls S, Feng X, White AT, and Hersh AL
- Subjects
- Anti-Bacterial Agents therapeutic use, Fluoroquinolones, Hospitals, Humans, Patient Discharge, Antimicrobial Stewardship, Community-Acquired Infections drug therapy, Pneumonia drug therapy, Urinary Tract Infections drug therapy
- Abstract
Background: Strategies to optimize antibiotic prescribing at discharge are not well understood., Methods: In fall 2019, we surveyed 39 Michigan hospitals on their antibiotic stewardship strategies. The association of reported strategies with discharge antibiotic overuse (unnecessary, excess, suboptimal fluoroquinolones) for community-acquired pneumonia (CAP) and urinary tract infection (UTI) was evaluated in 2 ways: (1) all strategies assumed equal weight and (2) strategies were weighted based on the ROAD (Reducing Overuse of Antibiotics at Discharge) Home Framework (ie, Tier 1-Critical infrastructure, Tier 2-Broad inpatient interventions, Tier 3-Discharge-specific strategies) with Tier 3 strategies receiving the highest weight., Results: Between 1 July 2017 and 30 July 2019, 39 hospitals with 20 444 patients (56.5% CAP; 43.5% UTI) were included. Survey response was 100%. Hospitals reported a median (interquartile range [IQR]) 12 (9-14) of 34 possible stewardship strategies. On analyses of individual stewardship strategies, the Tier 3 intervention, review of antibiotics prior to discharge, was the only strategy consistently associated with lower antibiotic overuse at discharge (adjusted incident rate ratio [aIRR] 0.543, 95% confidence interval [CI]: .335-.878). On multivariable analysis, weighting by ROAD Home tier predicted antibiotic overuse at discharge for both CAP and UTI. For diseases combined, having more weighted strategies was associated with lower antibiotic overuse at discharge (aIRR 0.957, 95% CI: .927-.987, per weighted intervention); discharge-specific stewardship strategies were associated with a 12.4% relative decrease in antibiotic overuse days at discharge., Conclusions: The more stewardship strategies a hospital reported, the lower its antibiotic overuse at discharge. However, Tier 3, or discharge-specific strategies, appeared to have the largest effect on antibiotic prescribing at discharge., Competing Interests: Potential conflicts of interest. S. F. reports personal fees from Wiley Publishing. A. H. reports receiving funding from the Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), and National Institutes of Health (NIH) outside of the submitted work; participation on a Data Safety Monitoring Board or Advisory Board for National Institute of Allergy and Infectious Diseases (NIAID) and leadership or fiduciary roles for the Pediatric Infectious Diseases Society (PIDS) and Infectious Diseases Society of America (IDSA). V. V. reports a related program grant from an unrelated Diagnostic Error grant from Betty and Gordon Moore Foundation, and an unrelated National Heart, Lung, and Blood Institute (NHLBI) loan repayment program and speaking fees for lecture on coronavirus disease (COVID) from Thermo Fisher Scientific. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2022
- Full Text
- View/download PDF
47. Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species - United States, January 2016-August 2022.
- Author
-
Accorsi EK, Chochua S, Moline HL, Hall M, Hersh AL, Shah SS, Britton A, Hawkins PA, Xing W, Onukwube Okaro J, Zielinski L, McGee L, Schrag S, and Cohen AL
- Subjects
- Child, Humans, Pandemics, SARS-CoV-2, Streptococcus, United States epidemiology, Anti-Infective Agents, Brain Abscess epidemiology, Brain Abscess microbiology, COVID-19, Empyema, Empyema, Subdural epidemiology, Epidural Abscess
- Abstract
In May 2022, CDC learned of three children in California hospitalized concurrently for brain abscess, epidural empyema, or subdural empyema caused by Streptococcus intermedius. Discussions with clinicians in multiple states raised concerns about a possible increase in pediatric intracranial infections, particularly those caused by Streptococcus bacteria, during the past year and the possible contributing role of SARS-CoV-2 infection (1). Pediatric bacterial brain abscesses, epidural empyemas, and subdural empyemas, rare complications of respiratory infections and sinusitis, are often caused by Streptococcus species but might also be polymicrobial or caused by other genera, such as Staphylococcus. On June 9, CDC asked clinicians and health departments to report possible cases of these conditions and to submit clinical specimens for laboratory testing. Through collaboration with the Children's Hospital Association (CHA), CDC analyzed nationally representative pediatric hospitalizations for brain abscess and empyema. Hospitalizations declined after the onset of the COVID-19 pandemic in March 2020, increased during summer 2021 to a peak in March 2022, and then declined to baseline levels. After the increase in summer 2021, no evidence of higher levels of intensive care unit (ICU) admission, mortality, genetic relatedness of isolates from different patients, or increased antimicrobial resistance of isolates was observed. The peak in cases in March 2022 was consistent with historical seasonal fluctuations observed since 2016. Based on these findings, initial reports from clinicians (1) are consistent with seasonal fluctuations and a redistribution of cases over time during the COVID-19 pandemic. CDC will continue to work with investigation partners to monitor ongoing trends in pediatric brain abscesses and empyemas., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Adam L. Hersh reports grants from the Agency for Health Research and Quality, participation on the National Institutes of Health Data and Safety Monitoring Board, and leadership or fiduciary roles in the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Lesley McGee reports support from the American Society for Microbiology and the International Symposium on Pneumococci and Pneumococcal Diseases for attending meetings and travel. Samir S. Shah reports grants from the Patient Centered Outcomes Research Institute and Children’s Hospital Association. No other potential conflicts of interest were disclosed.
- Published
- 2022
- Full Text
- View/download PDF
48. Respiratory virus testing and clinical outcomes among children hospitalized with pneumonia.
- Author
-
Shapiro DJ, Thurm CW, Hall M, Lipsett SC, Hersh AL, Ambroggio L, Shah SS, Brogan TV, Gerber JS, Grijalva CG, Blaschke AJ, Cogen JD, and Neuman MI
- Subjects
- Anti-Bacterial Agents therapeutic use, Child, Hospitalization, Hospitals, Pediatric, Humans, Infant, Pandemics, Retrospective Studies, United States epidemiology, COVID-19, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Pneumonia diagnosis, Viruses
- Abstract
Background: Despite the increased availability of diagnostic tests for respiratory viruses, their clinical utility for children with community-acquired pneumonia (CAP) remains uncertain., Objective: To identify patterns of respiratory virus testing across children's hospitals prior to the COVID-19 pandemic and to determine whether hospital-level rates of viral testing were associated with clinical outcomes., Design, Setting, and Participants: Multicenter retrospective cohort study of children hospitalized for CAP at 19 children's hospitals in the United States from 2010-2019., Main Outcomes and Measures: Using a novel method to identify the performance of viral testing, we assessed time trends in the use of viral tests, both overall and stratified by testing method. Adjusted proportions of encounters with viral testing were compared across hospitals and were correlated with length of stay, antibiotic and oseltamivir use, and performance of ancillary laboratory testing., Results: There were 46,038 hospitalizations for non-severe CAP among children without complex chronic conditions. The proportion with viral testing increased from 38.8% to 44.2% during the study period (p < .001). Molecular testing increased (27.2% to 40.0%, p < .001) and antigen testing decreased (33.2% to 7.8%, p < .001). Hospital-specific adjusted proportions of testing ranged from 10.0% to 83.5% and were not associated with length of stay, antibiotic use, or antiviral use. Hospitals that performed more viral testing did not have lower rates of ancillary laboratory testing., Conclusions: Viral testing practices varied widely across children's hospitals and were not associated with clinically important process or outcome measures. Viral testing may not influence clinical management for many children hospitalized with CAP., (© 2022 Society of Hospital Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
49. Association between antibiotic prescribing and visit duration among patients with respiratory tract infections.
- Author
-
Shapiro DJ, King LM, Tsay SV, Hicks LA, and Hersh AL
- Subjects
- Cross-Sectional Studies, Emergency Service, Hospital, Humans, Inappropriate Prescribing, Practice Patterns, Physicians', Anti-Bacterial Agents therapeutic use, Respiratory Tract Infections drug therapy
- Abstract
Time constraints have been suggested as a potential driver of antibiotic overuse for acute respiratory tract infections. In this cross-sectional analysis of national data from visits to offices and emergency departments, we identified no statistically significant association between antibiotic prescribing and the duration of visits for acute respiratory tract infections.
- Published
- 2022
- Full Text
- View/download PDF
50. Medications and Adherence to Treatment Guidelines Among Children Hospitalized With Acute COVID-19.
- Author
-
Burns JE, Thurm C, Antoon JW, Grijalva CG, Hall M, Hersh AL, Hester GZ, Korn E, Reyes MA, Shah SS, Totapally BR, and Teufel RJ
- Subjects
- Anti-Bacterial Agents therapeutic use, Child, Hospitalization, Humans, Pandemics, Retrospective Studies, COVID-19 Drug Treatment
- Abstract
Objectives: Coronavirus disease 2019 (COVID-19) treatment guidelines rapidly evolved during the pandemic. The December 2020 Infectious Diseases Society of America (IDSA) guideline, endorsed by the Pediatric Infectious Diseases Society, recommended steroids for critical disease, and suggested steroids and remdesivir for severe disease. We evaluated how medications for children hospitalized with COVID-19 changed after guideline publication., Methods: We performed a multicenter, retrospective cohort study of children aged 30 days to <18 years hospitalized with acute COVID-19 at 42 tertiary care US children's hospitals April 2020 to December 2021. We compared medication use before and after the December 2020 IDSA guideline (pre- and postguideline) stratified by COVID-19 disease severity (mild-moderate, severe, critical) with interrupted time series., Results: Among 18 364 patients who met selection criteria, 80.3% were discharged in the postguideline period. Remdesivir and steroid use increased postguideline relative to the preguideline period, although the trend slowed. Postguideline, among patients with severe disease, 75.4% received steroids and 55.2% remdesivir, and in those with critical disease, 82.4% received steroids and 41.4% remdesivir. Compared with preguideline, enoxaparin use increased overall but decreased among patients with critical disease. Postguideline, tocilizumab use increased and hydroxychloroquine, azithromycin, anakinra, and antibiotic use decreased. Antibiotic use remained high in severe (51.7%) and critical disease (81%)., Conclusions: Although utilization of COVID-19 medications changed after December 2020 IDSA guidelines, there was a decline in uptake and incomplete adherence for children with severe and critical disease. Efforts should enhance reliable delivery of guideline-directed therapies to children hospitalized with COVID-19 and assess their effectiveness., (Copyright © 2022 by the American Academy of Pediatrics.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.